INDO-GLOBAL ENT. | DR.AGAR.EYE | INDO-GLOBAL ENT./ DR.AGAR.EYE |
|||
---|---|---|---|---|---|
P/E (TTM) | x | -31.9 | 36.1 | - | View Chart |
P/BV | x | 1.4 | 14.8 | 9.8% | View Chart |
Dividend Yield | % | 0.0 | 0.1 | - |
INDO-GLOBAL ENT. DR.AGAR.EYE |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
INDO-GLOBAL ENT. Mar-20 |
DR.AGAR.EYE Mar-23 |
INDO-GLOBAL ENT./ DR.AGAR.EYE |
5-Yr Chart Click to enlarge
|
||
High | Rs | 20 | 1,580 | 1.3% | |
Low | Rs | 20 | 545 | 3.7% | |
Sales per share (Unadj.) | Rs | 0 | 570.0 | 0.0% | |
Earnings per share (Unadj.) | Rs | -0.7 | 78.6 | -0.8% | |
Cash flow per share (Unadj.) | Rs | -0.7 | 121.5 | -0.5% | |
Dividends per share (Unadj.) | Rs | 0 | 3.00 | 0.0% | |
Avg Dividend yield | % | 0 | 0.3 | 0.0% | |
Book value per share (Unadj.) | Rs | 11.1 | 241.1 | 4.6% | |
Shares outstanding (eoy) | m | 6.37 | 4.70 | 135.5% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 0 | 1.9 | - | |
Avg P/E ratio | x | -31.1 | 13.5 | -230.1% | |
P/CF ratio (eoy) | x | -31.1 | 8.7 | -355.9% | |
Price / Book Value ratio | x | 1.8 | 4.4 | 41.7% | |
Dividend payout | % | 0 | 3.8 | -0.0% | |
Avg Mkt Cap | Rs m | 130 | 4,994 | 2.6% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1 | 533 | 0.1% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 0 | 2,679 | 0.0% | |
Other income | Rs m | 0 | 21 | 0.0% | |
Total revenues | Rs m | 0 | 2,699 | 0.0% | |
Gross profit | Rs m | -1 | 756 | -0.2% | |
Depreciation | Rs m | 0 | 202 | 0.0% | |
Interest | Rs m | 1 | 80 | 0.9% | |
Profit before tax | Rs m | -2 | 494 | -0.4% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 2 | 125 | 1.6% | |
Profit after tax | Rs m | -4 | 369 | -1.1% | |
Gross profit margin | % | 0 | 28.2 | - | |
Effective tax rate | % | -93.4 | 25.3 | -369.8% | |
Net profit margin | % | 0 | 13.8 | - |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 0 | 465 | 0.0% | |
Current liabilities | Rs m | 7 | 964 | 0.7% | |
Net working cap to sales | % | 0 | -18.6 | - | |
Current ratio | x | 0 | 0.5 | 1.2% | |
Inventory Days | Days | 0 | 71 | - | |
Debtors Days | Days | 0 | 1 | - | |
Net fixed assets | Rs m | 80 | 3,750 | 2.1% | |
Share capital | Rs m | 64 | 47 | 135.5% | |
"Free" reserves | Rs m | 7 | 1,086 | 0.6% | |
Net worth | Rs m | 71 | 1,133 | 6.2% | |
Long term debt | Rs m | 2 | 358 | 0.7% | |
Total assets | Rs m | 80 | 4,216 | 1.9% | |
Interest coverage | x | -2.1 | 7.1 | -29.6% | |
Debt to equity ratio | x | 0 | 0.3 | 10.7% | |
Sales to assets ratio | x | 0 | 0.6 | 0.0% | |
Return on assets | % | -4.4 | 10.7 | -40.8% | |
Return on equity | % | -5.9 | 32.6 | -18.1% | |
Return on capital | % | -2.0 | 38.5 | -5.2% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 0 | 0 | - | |
Fx outflow | Rs m | 0 | 9 | 0.0% | |
Net fx | Rs m | 0 | -9 | -0.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | -1 | 696 | -0.2% | |
From Investments | Rs m | NA | -706 | -0.0% | |
From Financial Activity | Rs m | 1 | 3 | 52.7% | |
Net Cashflow | Rs m | 0 | -7 | -0.0% |
Indian Promoters | % | 2.8 | 71.9 | 3.9% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.0 | 0.6 | - | |
FIIs | % | 0.0 | 0.6 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 97.2 | 28.1 | 345.8% | |
Shareholders | 543 | 3,572 | 15.2% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare INDO-GLOBAL ENT. With: APOLLO HOSPITALS DR. LAL PATHLABS METROPOLIS HEALTHCARE KIMS NARAYANA HRUDAYALAYA
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | INDO-GLOBAL ENT. | DR.AGAR.EYE |
---|---|---|
1-Day | -4.76% | 2.56% |
1-Month | 6.24% | 14.25% |
1-Year | -13.28% | 201.35% |
3-Year CAGR | -7.78% | 122.18% |
5-Year CAGR | -4.74% | 58.53% |
* Compound Annual Growth Rate
Here are more details on the INDO-GLOBAL ENT. share price and the DR.AGAR.EYE share price.
Moving on to shareholding structures...
The promoters of INDO-GLOBAL ENT. hold a 2.8% stake in the company. In case of DR.AGAR.EYE the stake stands at 71.9%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of INDO-GLOBAL ENT. and the shareholding pattern of DR.AGAR.EYE.
Finally, a word on dividends...
In the most recent financial year, INDO-GLOBAL ENT. paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.
DR.AGAR.EYE paid Rs 3.0, and its dividend payout ratio stood at 3.8%.
You may visit here to review the dividend history of INDO-GLOBAL ENT., and the dividend history of DR.AGAR.EYE.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.